已收盤 07-31 16:00:00 美东时间
+0.140
+2.76%
今日重点评级关注:HC Wainwright & Co.:维持Greenwich LifeSciences"买入"评级,目标价从50美元升至69美元;高盛:维持Taysha Gene Therapies"买入"评级,目标价从11美元升至13美元
07-22 11:35
JP Morgan analyst Mark Strouse downgrades Array Technologies (NASDAQ:ARRY) from Overweight to Neutral and announces $8 price target.
07-21 22:40
今日重点评级关注:DA Davidson:维持Almonty Industries"买入"评级,目标价从25美元升至33美元;Stifel:维持Nurix Therapeutics"买入"评级,目标价从34美元升至40美元
07-13 10:13
Susquehanna analyst Biju Perincheril maintains Array Technologies (NASDAQ:ARRY) with a Neutral and lowers the price target from $9.5 to $7.25.
07-10 19:58
周二,美股太阳能板块普涨,Enphase Energy(ENPH.US)涨超7%,SolarEdge Technologies(SEDG.US)涨超7%,Su...
06-30 21:42
报道称美国联邦通信委员会正起草一项禁止进口外国逆变器的禁令,受此消息提振,美国太阳能技术股及相关公司周二盘前普遍上涨。 上涨股中:Enphase En...
06-30 20:35
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
UBS analyst Jon Windham maintains Array Technologies (NASDAQ:ARRY) with a Buy and raises the price target from $10 to $11.
05-08 06:34